Aberrant MicroRNAs in Pancreatic Cancer: Researches and Clinical Implications

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a high rate of mortality and poor prognosis. Numerous studies have proved that microRNA (miRNA) may play a vital role in a wide range of malignancies, including PDAC, and dysregulated miRNAs, including circulating miRNAs, are associated with PDAC proliferation, invasion, chemosensitivity, and radiosensitivity, as well as prognosis. Greater understanding of the roles of miRNAs in PDAC could provide insights into this disease and identify potential diagnostic markers and therapeutic targets. The current review focuses on recent advances with respect to the roles of miRNAs in PDAC and their practical value.

[1]  M. Korc,et al.  Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues. , 2008, Clinical chemistry.

[2]  K. Ohuchida,et al.  MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation , 2010, Molecular Cancer.

[3]  Huamin Wang,et al.  A novel epigenetic CREB-miR-373 axis mediates ZIP4-induced pancreatic cancer growth , 2013, EMBO molecular medicine.

[4]  L. Buscail,et al.  let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. , 2009, Human gene therapy.

[5]  M. Hashizume,et al.  MicroRNA-10a is Overexpressed in Human Pancreatic Cancer and Involved in Its Invasiveness Partially via Suppression of the HOXA1 Gene , 2012, Annals of surgical oncology.

[6]  P. Meltzer.  Cancer genomics: Small RNAs with big impacts , 2005, Nature.

[7]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[8]  Andreas Keller,et al.  MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors , 2012, PloS one.

[9]  G. Goodall,et al.  The microRNA-200 Family Regulates Epithelial to Mesenchymal Transition , 2008, TheScientificWorldJournal.

[10]  Ye Sun,et al.  Rapid and direct microRNA quantification by an enzymatic luminescence assay. , 2012, Analytical biochemistry.

[11]  Keith Bowman,et al.  Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs , 2005, Nature Biotechnology.

[12]  Moshe Oren,et al.  Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. , 2007, Molecular cell.

[13]  Q. Yao,et al.  Roles and Mechanisms of MicroRNAs in Pancreatic Cancer , 2011, World Journal of Surgery.

[14]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[15]  Bo Wang,et al.  Correction: MiR-130b Is a Prognostic Marker and Inhibits Cell Proliferation and Invasion in Pancreatic Cancer through Targeting STAT3 , 2013, PLoS ONE.

[16]  R. Mahato,et al.  miRNA profiling in pancreatic cancer and restoration of chemosensitivity. , 2013, Cancer letters.

[17]  Y. Niu,et al.  MiR-130b Is a Prognostic Marker and Inhibits Cell Proliferation and Invasion in Pancreatic Cancer through Targeting STAT3 , 2013, PloS one.

[18]  C. Croce,et al.  MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[19]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[20]  T. Andl.  miRNAs , 2007 .

[21]  Jingnan Li,et al.  ppENK Gene Methylation Status in the Development of Pancreatic Carcinoma , 2013, Gastroenterology research and practice.

[22]  E. Giovannetti,et al.  The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  A. Masamune,et al.  miR-210 regulates the interaction between pancreatic cancer cells and stellate cells. , 2013, Biochemical and biophysical research communications.

[24]  Xi Chen,et al.  Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. , 2012, Clinical chemistry.

[25]  A. Kallioniemi,et al.  Both inhibition and enhanced expression of miR‐31 lead to reduced migration and invasion of pancreatic cancer cells , 2012, Genes, chromosomes & cancer.

[26]  Y. Miao,et al.  miRNA-181b increases the sensitivity of pancreatic ductal adenocarcinoma cells to gemcitabine in vitro and in nude mice by targeting BCL-2. , 2013, Oncology reports.

[27]  Michael A. Beer,et al.  Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. , 2007, Molecular cell.

[28]  H. Taubert,et al.  Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival , 2010, International journal of cancer.

[29]  M. Neagu,et al.  Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers , 2011, Expert review of molecular diagnostics.

[30]  Hai-jiao Yan,et al.  miR-17-5p Inhibitor Enhances Chemosensitivity to Gemcitabine Via Upregulating Bim Expression in Pancreatic Cancer Cells , 2012, Digestive Diseases and Sciences.

[31]  J. Jacob,et al.  microRNAs as markers of survival and chemoresistance in pancreatic ductal adenocarcinoma , 2011, Expert review of anticancer therapy.

[32]  Thomas D. Schmittgen,et al.  Expression profiling identifies microRNA signature in pancreatic cancer , 2006, International journal of cancer.

[33]  D. Sahani,et al.  Radiology of pancreatic adenocarcinoma: Current status of imaging , 2007, Journal of gastroenterology and hepatology.

[34]  Quynh-Thu Le,et al.  Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer. , 2010, Translational oncology.

[35]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[36]  Huaizhi Wang,et al.  miR-204 mediated loss of Myeloid cell leukemia-1 results in pancreatic cancer cell death , 2013, Molecular Cancer.

[37]  Jian Li,et al.  MicroRNA-424-5p Suppresses the Expression of SOCS6 in Pancreatic Cancer , 2013, Pathology & Oncology Research.

[38]  M. Hung,et al.  A Tumorigenic Factor Interactome Connected through Tumor Suppressor MicroRNA-198 in Human Pancreatic Cancer , 2013, Clinical Cancer Research.

[39]  Jennifer P Morton,et al.  MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma , 2011, Clinical Cancer Research.

[40]  Mengtao Zhou,et al.  Pancreatic cancer: translational research aspects and clinical implications. , 2012, World journal of gastroenterology.

[41]  Jia Yu,et al.  miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer. , 2010, Cancer research.

[42]  P. Jansen,et al.  Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma. , 2012, Journal of hepatology.

[43]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[44]  T. Davison,et al.  MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma , 2007, Oncogene.

[45]  Tommaso Mazza,et al.  Mirna Expression Profiles Identify Drivers in Colorectal and Pancreatic Cancers , 2012, PloS one.

[46]  V. Ambros.  The functions of animal microRNAs , 2004, Nature.

[47]  E. Giovannetti,et al.  MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression. , 2014, Gastroenterology.

[48]  D. Goldenberg,et al.  New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  G. Bao,et al.  In vitro quantification of specific microRNA using molecular beacons , 2011, Nucleic acids research.

[50]  Carola Berking,et al.  Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer , 2008, Cell cycle.

[51]  Jun-dong Du,et al.  Expression of microRNA‐218 in human pancreatic ductal adenocarcinoma and its correlation with tumor progression and patient survival , 2014, Journal of surgical oncology.

[52]  Hailin Tang,et al.  Direct quantification of microRNA at low picomolar level in sera of glioma patients using a competitive hybridization followed by amplified voltammetric detection. , 2012, Analytical chemistry.

[53]  L. Castellano,et al.  Circulating peripheral blood mononuclear cells exhibit altered miRNA expression patterns in pancreatic cancer , 2013, Expert review of molecular diagnostics.

[54]  Wei Gong,et al.  Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significance , 2013, Journal of experimental & clinical cancer research : CR.

[55]  Takahiro Mine,et al.  Synthetic microRNA targeting glioma-associated antigen-1 protein. , 2009, Methods in molecular biology.

[56]  Yang Di,et al.  Elevated expression of tumor miR-222 in pancreatic cancer is associated with Ki67 and poor prognosis , 2013, Medical Oncology.

[57]  C. Croce,et al.  miRNA profiling of cancer. , 2013, Current opinion in genetics & development.

[58]  D. Jin,et al.  Combined Serum CA19-9 and miR-27a-3p in Peripheral Blood Mononuclear Cells to Diagnose Pancreatic Cancer , 2013, Cancer Prevention Research.

[59]  J. Abbruzzese,et al.  Synthetic MicroRNA Designed to Target Glioma-Associated Antigen 1 Transcription Factor Inhibits Division and Induces Late Apoptosis in Pancreatic Tumor Cells , 2006, Clinical Cancer Research.

[60]  Qizhi Yao,et al.  Profiling of 95 MicroRNAs in Pancreatic Cancer Cell Lines and Surgical Specimens by Real-Time PCR Analysis , 2009, World Journal of Surgery.

[61]  M. Goggins.  Identifying molecular markers for the early detection of pancreatic neoplasia. , 2007, Seminars in oncology.

[62]  Wendy Frankel,et al.  MicroRNA-21 is Overexpressed in Pancreatic Cancer and a Potential Predictor of Survival , 2008, Journal of Gastrointestinal Surgery.

[63]  R. Hruban,et al.  Serum miR-1290 as a Marker of Pancreatic Cancer—Response , 2013, Clinical Cancer Research.

[64]  L. Tran,et al.  Endoscopically Acquired Pancreatic Cyst Fluid MicroRNA 21 and 221 Are Associated With Invasive Cancer , 2013, The American Journal of Gastroenterology.

[65]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[66]  S. Batra,et al.  MicroRNA-200c Modulates the Expression of MUC4 and MUC16 by Directly Targeting Their Coding Sequences in Human Pancreatic Cancer , 2013, PloS one.

[67]  Zhihui Feng,et al.  A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer. , 2009, Gynecologic oncology.

[68]  G. Rechavi,et al.  MicroRNA expression signatures in intraductal papillary mucinous neoplasm of the pancreas. , 2013, Surgery.

[69]  D. Ichikawa,et al.  Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer , 2013, British Journal of Cancer.

[70]  Yuriy Gusev,et al.  Real-time expression profiling of microRNA precursors in human cancer cell lines , 2005, Nucleic acids research.

[71]  P. Singh,et al.  MicroRNAs in pancreatic cancer metabolism , 2012, Nature Reviews Gastroenterology &Hepatology.

[72]  Zhaohui Lu,et al.  miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2. , 2010, Cancer letters.

[73]  Miss A.O. Penney.  (b) , 1974, The New Yale Book of Quotations.

[74]  A. Fire,et al.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.

[75]  Thomas D. Schmittgen,et al.  Antisense Inhibition of microRNA-21 or -221 Arrests Cell Cycle, Induces Apoptosis, and Sensitizes the Effects of Gemcitabine in Pancreatic Adenocarcinoma , 2009, Pancreas.

[76]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[77]  Y. Gong,et al.  Combination of plasma microRNAs with serum CA19‐9 for early detection of pancreatic cancer , 2012, International journal of cancer.

[78]  A. Harris,et al.  Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma , 2008, British journal of haematology.

[79]  Taiping Zhang,et al.  Advances in early diagnosis and therapy of pancreatic cancer. , 2011, Hepatobiliary & pancreatic diseases international : HBPD INT.

[80]  Yong-Tae Kim,et al.  Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer , 2010, PloS one.

[81]  Sirong He,et al.  MicroRNA-221 Mediates the Effects of PDGF-BB on Migration, Proliferation, and the Epithelial-Mesenchymal Transition in Pancreatic Cancer Cells , 2013, PloS one.

[82]  Ann M. Killary,et al.  MicroRNAs in Plasma of Pancreatic Ductal Adenocarcinoma Patients as Novel Blood-Based Biomarkers of Disease , 2009, Cancer Prevention Research.

[83]  L. Buscail,et al.  The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis. , 2010, Clinical chemistry.

[84]  Zhiwei Wang,et al.  Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF. , 2010, Cancer research.

[85]  R. Yantiss,et al.  MicroRNA Expression Aids the Preoperative Diagnosis of Pancreatic Ductal Adenocarcinoma , 2012, Pancreas.

[86]  K. Ohuchida,et al.  MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance , 2009, Molecular Cancer Therapeutics.

[87]  C. Croce,et al.  miRNAs, Cancer, and Stem Cell Division , 2005, Cell.

[88]  G. Weiss,et al.  MicroRNAs and cancer: past, present, and potential future , 2008, Molecular Cancer Therapeutics.

[89]  J. Hoheisel,et al.  Diagnosis of Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis by Measurement of microRNA Abundance in Blood and Tissue , 2012, PloS one.

[90]  N. Rajewsky,et al.  A pancreatic islet-specific microRNA regulates insulin secretion , 2004, Nature.

[91]  Anastasia Khvorova,et al.  Off-target effects by siRNA can induce toxic phenotype. , 2006, RNA.

[92]  C. Croce,et al.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[93]  Ugo Boggi,et al.  MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. , 2010, Cancer research.

[94]  Guoqiang Zhao,et al.  MiR-148a regulates the growth and apoptosis in pancreatic cancer by targeting CCKBR and Bcl-2 , 2013, Tumor Biology.

[95]  Zhaoshen Li,et al.  Aberrant microRNAs expression patterns in pancreatic cancer and their clinical translation. , 2013, Cancer biotherapy & radiopharmaceuticals.

[96]  C. Croce,et al.  MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. , 2007, JAMA.

[97]  Qizhi Yao,et al.  MicroRNAs: Control and Loss of Control in Human Physiology and Disease , 2009, World Journal of Surgery.

[98]  Zhiwei Wang,et al.  miR-146a suppresses invasion of pancreatic cancer cells. , 2010, Cancer research.

[99]  A. Masamune,et al.  MiR-365 induces gemcitabine resistance in pancreatic cancer cells by targeting the adaptor protein SHC1 and pro-apoptotic regulator BAX. , 2014, Cellular signalling.

[100]  Wenlin Huang,et al.  MicroRNA-20a overexpression inhibited proliferation and metastasis of pancreatic carcinoma cells. , 2010, Human gene therapy.

[101]  Yitao Ding,et al.  Associations of miR-499 and miR-34b/c Polymorphisms with Susceptibility to Hepatocellular Carcinoma: An Evidence-Based Evaluation , 2013, Gastroenterology research and practice.

[102]  Lianyu Chen,et al.  MicroRNA 23b regulates autophagy associated with radioresistance of pancreatic cancer cells. , 2013, Gastroenterology.

[103]  Y. Gong,et al.  Detection of Differentially Expressed microRNAs in Serum of Pancreatic Ductal Adenocarcinoma Patients: miR-196a Could Be a Potential Marker for Poor Prognosis , 2011, Digestive Diseases and Sciences.

[104]  이화영.  X , 1960, Chinese Plants Names Index 2000-2009.

[105]  Michael Z Michael,et al.  Reduced accumulation of specific microRNAs in colorectal neoplasia. , 2003, Molecular cancer research : MCR.

[106]  Kun Wang,et al.  The serum miR‐21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR‐21 expression confers chemoresistance by targeting FasL , 2013, Molecular oncology.

[107]  H. Eguchi,et al.  MicroRNA-29a induces resistance to gemcitabine through the Wnt/β-catenin signaling pathway in pancreatic cancer cells. , 2013, International journal of oncology.

[108]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[109]  H. Eguchi,et al.  miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1 , 2013, British Journal of Cancer.

[110]  S. Sen,et al.  Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa‐mir‐155 in human pancreatic ductal adenocarcinoma , 2014, Molecular carcinogenesis.